Satralizumab, previously known as compound SA-237 , represents a exciting treatment for a form of multiple sclerosis and other inflammatory diseases . Latest studies have demonstrated encouraging results https://bookmarks-hit.com/story25608999/satralizumab-a-deep-dive-into-sa-237-s-research-development